Home > Protocol Summaries: Compounds > Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine (KFT)

Protocol Summaries: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine (KFT)

GSK Study ID	Phase	Title	Status
104489	Phase 3	Study to assess immunogenicity & safety of GSK Bio Kft’s DTPw-HBV/Hib vs DTPwCSL-HBV/Hib Kft & vs concomitant administration of CSL’s Triple Antigen & Hiberix (GSK Bio), to infants 2,4,6 mths of age, after a birth dose of hep B	Terminated